Anticoagulation control with ACT (activated clotting time) during interventional neuroradiology;Antikoagulationskontrolle bei neuroradiologisch interventionellen eingriffen mit ACT (activated clotting time)

RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Neuen Bildgebenden Verfahren

Volumn 170, Issue 4, 1999, Pages 378-383

  Berlis, A ^a,b   Schumacher, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Activated clotting time; Heparin; Interventional neuroradiology; Protamin

Indexed keywords

HEPARIN; PROTAMINE; ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TIME; BRAIN HEMORRHAGE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG MONITORING; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; THROMBOEMBOLISM; BLOOD; BLOOD CLOTTING TEST; CEREBROVASCULAR DISEASE; COMPARATIVE STUDY; INTERVENTIONAL RADIOLOGY; INTRAARTERIAL DRUG ADMINISTRATION; METHODOLOGY; NEURORADIOLOGY; NONPARAMETRIC TEST; RADIOGRAPHY; REGRESSION ANALYSIS; STATISTICS; TIME;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; CEREBROVASCULAR DISORDERS; HEPARIN; HUMANS; INFUSIONS, INTRA-ARTERIAL; NEURORADIOGRAPHY; RADIOGRAPHY, INTERVENTIONAL; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC; TIME FACTORS; WHOLE BLOOD COAGULATION TIME;

EID: 0032588381     PISSN: 09366652     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Hattersley PG: Activated coagulation time of whole blood. J Amer Med Ass 1966; 196: 150-154
2. Bowers J, Ferguson JJ 3rd: The use of activated clotting times to monitor heparin therapy during and after interventional procedures. Clin Cardiol 1994; 17: 357-361
3. Nakagawa T, Kubota T, Handa Y, Kawano H, Sato K: Intracranial hemorrhage due to long-term anticoagulant therapy in patients with prosthetic heart valves - four case reports. Neurol Med Chir 1995; 35: 156-159
4. Fujii Y, Takeuchi S, Koike T, Nishimaki K, Ito Y, Tanaka R, Okamoto K: Heparin administration and monitoring for neuroangiography. Amer J Neuroradiol 1994; 15: 51-54
5. Scott JA, Berenstein A, Blumenthal D: Use of the activated coagulation time as a measure of anticoagulation during interventional procedures. Radiology 1986; 158: 849-850
6. Cronqvist M, Pierot L, Boulin A, Cognard C, Castaings L, Moret J: Local intraarterial fibrinolysis of thromboemboli occurring during endovascular treatment of intracerebral aneurysm: a comparison of anatomic results and clinical outcome. Amer J Neuroradiol 1998; 19: 157-165
7. Jaenecke J: Antikoagulanzien- und Fibrinolysetherapie. Stuttgart. Thieme 1990: 17-20
8. Dion JE, Gates PC, Fox AJ, Barnett HJ, Blom RJ: Clinical events following neuroangiography: a prospective study. Stroke 1987; 18: 997-1004
9. 9 Earnest F, Forbes G, Sandok BA, Piepgras DG, Faust RJ, Ilstrup DM, Arndt LJ: Complications of cerebral angiography: prospective assessment of risk. Amer J Roentgenol 1984; 142: 247-253
10. Grzyska U, Freitag J, Zeumer H: Selective cerebral intraarterial DAS: complication rate and control of risk factors. Neuroradiology 1990; 32: 296-299
11. Heisermann JE, Dean BL, HodakJA, Flom RA, Bird CR, Drayer BP, Fram EK: Neurologic complications of cerebral angiography. Amer J Neuroradiol 1994; 15: 1401-1407
12. Kachel R, Jahn U, Schiffmann R, Basche S: Komplikationen bei zerebraler Angiographie. Eine Studie über 6698 zerebrale Angiographien. Rev Med Chir Soc med Nat Iasi 1991; 95: 97-105
13. Gabrielsen TO: Neurologic complications of cerebral angiography. Amer J Neuroradiol 1994; 15: 1408-1411
14. Markus H, Loh A, Israel D, Buckenham T, Clifton A, Brown M: Microscopic air embolism during cerebral angiography and strategies for its avoidance. Lancet 1993; 341: 784-787
15. Gallus AS, Hirsh J: Antithrombotic Drugs, Part I. Curr Therapy 1976; 17: 121-145
16. Ehret MH, Nuttall GA, Klindworth JT, Mac Veih I, Santrach PJ, Orszulak TA, Harmsen WS, Oliver WC Jr: Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? Anaesth Analg 1997; 85: 259-264
17. Cola C, Ansell J: Heparin-induced thrombocytopenia and arterial thrombosis. Alternative therapies. Amer Heart J 1990; 2: 368
18. Laster J, Crikit D, Walker N, Silver D: The heparin-induced thrombocytopenia syndrome. An update. Surgery 1987; 4: 763
19. Prull A, Nechwatal R, Riedel H, Mäurer W: Therapie des Heparininduzierten Thrombose-Thrombozytopenie-Syndroms mit Immunglobulinen. Dtsch Med Wschr 1992; 117: 1838-1842
20. Kemkes-Matthes B: Heparin-induzierte Thrombozytopenie. Arzneimitteltherapie 1997; 15: 212-214
21. Stammler F, Diehm C: Niedermolekulare Heparine bei venöser Thromboembolie. Dtsch Med Wschr 1998; 123: 604-611
22. Inoue M, Hirose Y, Gamou M, Goto M: Effect of hemodilution with dextran and albumin on activated clotting time. Masui 1997; 46: 809-812
23. Merhi Y, Bernier J, Marois Y, Guidoin R: Acute thrombogenicity of arterial prostheses exposed to reduced blood flow in dogs: effects of heparin, aspirin, and prostacyclin. J Cardiovasc Pharmacol 1995; 26: 1-5
24. Forth W, Henschler D, Rummel W: Allgemeine und spezielle Pharmakologie und Toxikologie. Mannheim. Wissenschaftsverlag 1988: 319-321
25. Chargaff E, Olson KB: Studies on chemistry of blood coagulation. VI. Studies on action of heparin and other anticoagulants. Influence of protamin on anticoagulant effect in vivo. J Biol Chem 1937; 122: 153-167
26. Blumenthal RS, Carter AJ, Resar JR, Coombs V, Goth ST, Dalal J, Brinker JA: Comparison of bedside and hospital laboratory coagulation studies during and after coronary intervention. Cathet Cardiovasc Diagn 1995; 35: 9-17